NEUBASE THERAPEUTICS, INC. Quotes NeuBase Therapeutics, Inc. Nasdaq
Equities
NBSE
US64132K2015
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.378 USD | -3.20% |
|
-.--% | -48.93% |
Performance
| 1 day | -3.20% | ||
| 3 months | -60.99% | ||
| 6 months | -46.00% | ||
| Current year | -48.93% | ||
| 1 year | -86.05% | ||
| 3 years | -99.64% |
Volumes
marketsDaily volume
97 744
Estimated daily volume
97 744
Record volume 1
106 711 132
Record volume 2
14 760 468
Record volume 3
10 664 850
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
1 391 020
Net sales (USD)
0
Number of employees
37
Sales / Employee (USD)
0
Free-Float
86.62 %
Free-Float capitalization (USD)
1 204 928
Highs and lows
Current year
0.36
1.15
1 year
0.363.48
3 years
0.36109.00
5 years
0.36257.80
10 years
0.36257.80
Indicators
Moving average 5 days
0.40
Moving average 20 days
0.42
Moving average 50 days
0.60
Moving average 100 days
0.65
Price spread / (MMA5)
+5.16%
Price spread / (MMA20)
+9.79%
Price spread / (MMA50)
+59.42%
Price spread / (MMA100)
+71.67%
RSI 9 days
27.81
RSI 14 days
30.81
Sector Comparison - Other Biotechnology & Medical Research
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -3.20% | -.--% | -48.93% | -86.05% | 1.39M | ||
| -3.58% | -7.27% | +40.80% | +7.73% | 53.67B | ||
| -0.17% | -3.98% | +35.79% | -14.93% | 38.86B | ||
| -0.57% | -2.96% | -8.05% | -1.86% | 38.76B | ||
| +0.44% | -4.03% | -8.98% | +11.76% | 27.27B | ||
| -1.44% | -1.86% | +10.69% | +34.12% | 25.91B | ||
| +0.21% | +4.98% | -16.21% | -20.73% | 20.29B | ||
| +0.16% | +4.75% | +31.00% | +25.47% | 12.78B | ||
| -0.05% | -1.81% | +28.51% | +78.55% | 12.18B | ||
| -1.31% | -2.27% | -1.67% | -0.97% | 11.96B | ||
| -1.40% | -2.48% | -11.39% | +0.24% | 10.79B | ||
| -2.33% | -5.60% | -5.43% | -11.83% | 9.39B | ||
| -0.31% | +1.02% | +21.92% | -7.47% | 6.67B | ||
| +8.78% | 0.00% | - | - | 6.65B | ||
| -0.79% | +2.14% | +14.43% | +73.35% | 6.61B | ||
| -2.82% | -4.26% | +34.66% | +53.62% | 6.37B | ||
| Average | -0.52% | -1.52% | +7.81% | +9.40% | ||
| Weighted average by Cap. | -0.90% | -2.67% | +14.15% | +8.83% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -48.93% | ||
| 2023 | -80.54% | ||
| 2022 | -93.23% | ||
| 2021 | -59.80% | ||
| 2020 | -2.92% | ||
| 2019 | +58.24% |
- Stock Market
- Equities
- O7P Stock
- NBSE Stock
- Quotes NeuBase Therapeutics, Inc.
